Effect of miR-128 in DNA damage of HL-60 acute myeloid leukemia cells

Current Pharmaceutical Biotechnology

Volumn 15, Issue 5, 2014, Pages 492-502

  Seca, Hugo ^a   Lima, Raquel T ^a   Almeida, Gabriela M ^a   Sobrinho Simões, Manuel ^a,b   Bergantim, Rui ^a,b   Guimarães, José E ^a,b   Vasconcelos, M Helena ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

Acute myeloid leukemia; DNA damage; HL 60; miR 128

Indexed keywords

DOXORUBICIN; ETOPOSIDE; MICRORNA; MICRORNA 128; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; APOPTOSIS REGULATORY PROTEIN; MIRN128 MICRORNA, HUMAN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL COUNT; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DRUG SENSITIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; HL 60 CELL LINE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; NICK END LABELING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRYPAN BLUE ASSAY; WESTERN BLOTTING; BIOSYNTHESIS; CELL SURVIVAL; DRUG EFFECTS; METABOLISM;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELL PROLIFERATION; CELL SURVIVAL; DNA DAMAGE; DOXORUBICIN; ETOPOSIDE; HL-60 CELLS; HUMANS; MICRORNAS; TRANSFECTION;

EID: 84907184167     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201015666140519122524     Document Type: Article

References (61)

1. Esquela-Kerscher, A.; Slack, F. J. Oncomirs-microRNAs with a role in cancer. Nature Rev. Cancer, 2006, 6(4), 259-269.
2. Garzon, R.; Calin, G. A.; Croce, C. M. MicroRNAs in Cancer. Ann. Rev. Med., 2009, 60, 167-179.
3. Borralho, P. M.; Simoes, A. E.; Gomes, S. E.; Lima, R. T.; Carvalho, T.; Ferreira, D. M.; Vasconcelos, M. H.; Castro, R. E.; Rodrigues, C. M. miR-143 overexpression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation. Plos One, 2011, 6(8), e23787.
4. Lima, R. T.; Busacca, S.; Almeida, G. M.; Gaudino, G.; Fennell, D. A.; Vasconcelos, M. H. MicroRNA regulation of core apoptosis pathways in cancer. Eur. J. Cancer, 2011, 47(2), 163-174.
5. Ciafre, S. A.; Galardi, S.; Mangiola, A.; Ferracin, M.; Liu, C. G.; Sabatino, G.; Negrini, M.; Maira, G.; Croce, C. M.; Farace, M. G. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophysic. Res. Commun., 2005, 334(4), 1351-1358.
6. Mi, S.; Lu, J.; Sun, M.; Li, Z.; Zhang, H.; Neilly, M. B.; Wang, Y.; Qian, Z.; Jin, J.; Zhang, Y.; Bohlander, S. K.; Le Beau, M. M.; Larson, R. A.; Golub, T. R.; Rowley, J. D.; Chen, J. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc. Natl. Acad. Sci. USA, 2007, 104(50), 19971-19976.
7. Marcucci, G.; Radmacher, M. D.; Maharry, K.; Mrozek, K.; Ruppert, A. S.; Paschka, P.; Vukosavljevic, T.; Whitman, S. P.; Baldus, C. D.; Langer, C.; Liu, C. G.; Carroll, A. J.; Powell, B. L.; Garzon, R.; Croce, C. M.; Kolitz, J. E.; Caligiuri, M. A.; Larson, R. A.; Bloomfield, C. D. MicroRNA expression in cytogenetically normal acute myeloid leukemia. New Engl. J. Med., 2008, 358(18), 1919-1928.
8. Weiss, G. J.; Bemis, L. T.; Nakajima, E.; Sugita, M.; Birks, D. K.; Robinson, W. A.; Varella-Garcia, M.; Bunn, P. A., Jr.; Haney, J.; Helfrich, B. A.; Kato, H.; Hirsch, F. R.; Franklin, W. A., EGFR regulation by microRNA in lung cancer: Correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Annals Oncol., 2008, 19(6), 1053-1059.
9. Evangelisti, C.; Florian, M. C.; Massimi, I.; Dominici, C.; Giannini, G.; Galardi, S.; Bue, M. C.; Massalini, S.; McDowell, H. P.; Messi, E.; Gulino, A.; Farace, M. G.; Ciafre, S. A. MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness. FASEB J., 2009, 23(12), 4276-4287.
10. Godlewski, J.; Nowicki, M. O.; Bronisz, A.; Williams, S.; Otsuki, A.; Nuovo, G.; Raychaudhury, A.; Newton, H. B.; Chiocca, E. A.; Lawler, S. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and selfrenewal. Cancer Res., 2008, 68(22), 9125-9130.
11. Zhang, Y.; Chao, T.; Li, R.; Liu, W.; Chen, Y.; Yan, X.; Gong, Y.; Yin, B.; Liu, W.; Qiang, B.; Zhao, J.; Yuan, J.; Peng, X. MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J. Molecul. Med., 2009, 87(1), 43-51.
12. Cui, J. G.; Zhao, Y.; Sethi, P.; Li, Y. Y.; Mahta, A.; Culicchia, F.; Lukiw, W. J. Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation. J. Neuro-Oncol., 2010, 98(3), 297-304.
13. Venkataraman, S.; Alimova, I.; Fan, R.; Harris, P.; Foreman, N.; Vibhakar, R. MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence. Plos One, 2010, 5(6), e10748.
14. Palumbo, T.; Faucz, F. R.; Azevedo, M.; Xekouki, P.; Iliopoulos, D.; Stratakis, C. A. Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway. Oncogene, 2013, 32(13), 1651-1659.
15. Zhu, Y.; Yu, F.; Jiao, Y.; Feng, J.; Tang, W.; Yao, H.; Gong, C.; Chen, J.; Su, F.; Zhang, Y.; Song, E. Reduced miR-128 in breast tumor-initiating cells induces chemotherapeutic resistance via Bmi-1 and ABCC5. Clin. Cancer Res., 2011, 17(22), 7105-7115.
16. Adlakha, Y. K.; Saini, N. MicroRNA-128 downregulates Bax and induces apoptosis in human embryonic kidney cells. Cellular Molecul. Life Sci., 2011, 68(8), 1415-1428.
17. Ji, S.; Shao, G.; Lv, X.; Liu, Y.; Fan, Y.; Wu, A.; Hu, H. Downregulation of miRNA-128 sensitises breast cancer cell to chemodrugs by targeting Bax. Cell Biol. Int., 2013.
18. Guidi, M.; Muinos-Gimeno, M.; Kagerbauer, B.; Marti, E.; Estivill, X.; Espinosa-Parrilla, Y., Overexpression of miR-128 specifically inhibits the truncated isoform of NTRK3 and upregulates BCL2 in SH-SY5Y neuroblastoma cells. BMC Molecul. Biol., 2010, 11, 95.
19. Adlakha, Y. K.; Saini, N., miR-128 exerts pro-apoptotic effect in a p53 transcription-dependent and-independent manner via PUMABak axis. Cell Death Dis., 2013, 4, e542.
20. Masri, S.; Liu, Z.; Phung, S.; Wang, E.; Yuan, Y. C.; Chen, S. The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells. Breast Cancer Res. Treatment, 2010, 124(1), 89-99.
21. Shi, Z. M.; Wang, J.; Yan, Z.; You, Y. P.; Li, C. Y.; Qian, X.; Yin, Y.; Zhao, P.; Wang, Y. Y.; Wang, X. F.; Li, M. N.; Liu, L. Z.; Liu, N.; Jiang, B. H., MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1. Plos One, 2012, 7(3), e32709.
22. Papagiannakopoulos, T.; Friedmann-Morvinski, D.; Neveu, P.; Dugas, J. C.; Gill, R. M.; Huillard, E.; Liu, C.; Zong, H.; Rowitch, D. H.; Barres, B. A.; Verma, I. M.; Kosik, K. S. Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. Oncogene, 2012, 31(15), 1884-1895.
23. Khan, A. P.; Poisson, L. M.; Bhat, V. B.; Fermin, D.; Zhao, R.; Kalyana-Sundaram, S.; Michailidis, G.; Nesvizhskii, A. I.; Omenn, G. S.; Chinnaiyan, A. M.; Sreekumar, A. Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer. Molecul. Cellul. Proteomics, 2010, 9(2), 298-312.
24. Woo, H. H.; Laszlo, C. F.; Greco, S.; Chambers, S. K. Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152. Molecul. Cancer, 2012, 11(1), 58.
25. Diaz-Beya, M.; Navarro, A.; Ferrer, G.; Diaz, T.; Gel, B.; Camos, M.; Pratcorona, M.; Torrebadell, M.; Rozman, M.; Colomer, D.; Monzo, M.; Esteve, J. Acute myeloid leukemia with translocation (8; 16)(p11; p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene. Leukemia, 2013, 27(3), 595-603.
26. Nanta, R.; Kumar, D.; Meeker, D.; Rodova, M.; Van Veldhuizen, P. J.; Shankar, S.; Srivastava, R. K. NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rgamma null mice by regulating Bmi-1 and microRNA-128. Oncogenesis, 2013, 2, e42.
27. Wu, N.; Wu, G. C.; Hu, R.; Li, M.; Feng, H. Ginsenoside Rh2 inhibits glioma cell proliferation by targeting microRNA-128. Acta Pharmacologic. Sinica, 2011, 32(3), 345-353.
28. Frohling, S.; Scholl, C.; Gilliland, D. G.; Levine, R. L. Genetics of myeloid malignancies: pathogenetic and clinical implications. J. Clin. Oncol., 2005, 23(26), 6285-6295.
29. Mrozek, K.; Heerema, N. A.; Bloomfield, C. D. Cytogenetics in acute leukemia. Blood Rev., 2004, 18(2), 115-36.
30. Dohner, H. Implication of the molecular characterization of acute myeloid leukemia. Hematology/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 2007, 412-419.
31. Zhu, Y. D.; Wang, L.; Sun, C.; Fan, L.; Zhu, D. X.; Fang, C.; Wang, Y. H.; Zou, Z. J.; Zhang, S. J.; Li, J. Y.; Xu, W. Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia. Medical Oncol., 2012, 29(4), 2323-2331.
32. Seca, H.; Almeida, G. M.; Guimaraes, J. E.; Vasconcelos, M. H. miR signatures and the role of miRs in acute myeloid leukaemia. Europ. J. Cancer, 2010, 46(9), 1520-1527.
33. Seca, H.; Lima, R. T.; Guimaraes, J. E.; Vasconcelos, M. H. Simultaneous targeting of P-gp and XIAP with siRNAs increases sensitivity of P-gp overexpressing CML cells to imatinib. Hematology, 2011, 16(2), 100-108.
34. Lima, R. T.; Seca, H.; Soares, P.; Nascimento, M. S.; Vasconcelos, M. H. EBV interferes with the sensitivity of Burkitt lymphoma Akata cells to etoposide. J. Cellul. Biochem., 2011, 112(1), 200-210.
35. Vasconcelos, M. H.; Beleza, S. S.; Quirk, C.; Maia, L. F.; Sambade, C.; Guimaraes, J. E. Limited synergistic effect of antisense oligonucleotides against bcr-abl and transferrin receptor mRNA in leukemic cells in culture. Cancer Lett., 2000, 152(2), 135-143.
36. Lima, R. T.; Martins, L. M.; Guimaraes, J. E.; Sambade, C.; Vasconcelos, M. H. Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells. Cancer Gene Therap., 2004, 11(5), 309-316.
37. Lima, R. T.; Martins, L. M.; Guimaraes, J. E.; Sambade, C.; Vasconcelos, M. H. Chemosensitization effects of XIAP downregulation in K562 leukemia cells. J. Chemotherap., 2006, 18(1), 98-102.
38. Queiroz, M. J.; Calhelha, R. C.; Vale-Silva, L. A.; Pinto, E.; Almeida, G. M.; Vasconcelos, M. H. Synthesis and evaluation of tumor cell growth inhibition of methyl 3-amino-6-[(hetero)arylethynyl]thieno[3, 2-b]pyridine-2-carboxylates. Structure-activity relationships, effects on the cell cycle and apoptosis. Euro. J. Medicin. Chem., 2011, 46(1), 236-240.
39. Preto, A.; Goncalves, J.; Rebocho, A. P.; Figueiredo, J.; Meireles, A. M.; Rocha, A. S.; Vasconcelos, H. M.; Seca, H.; Seruca, R.; Soares, P.; Sobrinho-Simoes, M. Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations. BMC Cancer, 2009, 9, 387.
40. Queiroz, M. J.; Calhelha, R. C.; Vale-Silva, L. A.; Pinto, E.; Lima, R. T.; Vasconcelos, M. H. Efficient synthesis of 6-(hetero)arylthieno [3, 2-b]pyridines by Suzuki-Miyaura coupling. Evaluation of growth inhibition on human tumor cell lines, SARs and effects on the cell cycle. Euro. J. Medicin. Chem., 2010, 45(12), 5628-5634.
41. Markova, E.; Schultz, N.; Belyaev, I. Y. Kinetics and dose-response of residual 53BP1/gamma-H2AX foci: co-localization, relationship with DSB repair and clonogenic survival. Int. J. Radiat. Biol., 2007, 83(5), 319-329.
42. Kozomara, A.; Griffiths-Jones, S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res., 2011, 39 (Database issue), D152-7.
43. Lujambio, A.; Lowe, S. W. The microcosmos of cancer. Nature, 2012, 482(7385), 347-355.
44. Smirnova, L.; Grafe, A.; Seiler, A.; Schumacher, S.; Nitsch, R.; Wulczyn, F. G. Regulation of miRNA expression during neural cell specification. Euro. J. Neurosci., 2005, 21(6), 1469-1477.
45. Pluchino, K. M.; Hall, M. D.; Goldsborough, A. S.; Callaghan, R.; Gottesman, M. M. Collateral sensitivity as a strategy against cancer multidrug resistance. Drug Resistance Updat.: Rev. Commentaries Antimicrob. Anticancer Chemotherap., 2012, 15(1-2), 98-105.
46. Amiri-Kordestani, L.; Basseville, A.; Kurdziel, K.; Fojo, A. T.; Bates, S. E. Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies. Drug Resistance Updat.: Rev Commentaries Antimicrob. Anticancer Chemotherap., 2012, 15(1-2), 50-61.
47. Giovannetti, E.; Erozenci, A.; Smit, J.; Danesi, R.; Peters, G. J. Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice. Crit. Rev. Oncol./Hematol., 2012, 81(2), 103-122.
48. Ma, J.; Dong, C.; Ji, C., MicroRNA and drug resistance. Cancer gene therapy 2010, 17 (8), 523-31.
49. Donzelli, S.; Fontemaggi, G.; Fazi, F.; Di Agostino, S.; Padula, F.; Biagioni, F.; Muti, P.; Strano, S.; Blandino, G., MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function. Cell Death Differentiat., 2012, 19 (6), 1038-1048.
50. Qian, P.; Banerjee, A.; Wu, Z. S.; Zhang, X.; Wang, H.; Pandey, V.; Zhang, W. J.; Lv, X. F.; Tan, S.; Lobie, P. E.; Zhu, T. Loss of SNAIL regulated miR-128-2 on chromosome 3p22. 3 targets multiple stem cell factors to promote transformation of mammary epithelial cells. Cancer Res., 2012, 72(22), 6036-6050.
51. Knaapen, M. W.; Davies, M. J.; De Bie, M.; Haven, A. J.; Martinet, W.; Kockx, M. M. Apoptotic versus autophagic cell death in heart failure. Cardiovasc. Res., 2001, 51(2), 304-312.
52. Grasl-Kraupp, B.; Ruttkay-Nedecky, B.; Koudelka, H.; Bukowska, K.; Bursch, W.; Schulte-Hermann, R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note. Hepatology, 1995, 21(5), 1465-1468.
53. Kunchithapautham, K.; Rohrer, B. Apoptosis and autophagy in photoreceptors exposed to oxidative stress. Autophagy, 2007, 3(5), 433-441.
54. Salazar, M.; Carracedo, A.; Salanueva, I. J.; Hernandez-Tiedra, S.; Lorente, M.; Egia, A.; Vazquez, P.; Blazquez, C.; Torres, S.; Garcia, S.; Nowak, J.; Fimia, G. M.; Piacentini, M.; Cecconi, F.; Pandolfi, P. P.; Gonzalez-Feria, L.; Iovanna, J. L.; Guzman, M.; Boya, P.; Velasco, G. Cannabinoid action induces autophagymediated cell death through stimulation of ER stress in human glioma cells. J. Clin. Investigat., 2009, 119(5), 1359-1372.
55. Han, C.; Wan, G.; Langley, R. R.; Zhang, X.; Lu, X. Crosstalk between the DNA damage response pathway and microRNAs. Cellular Molecul. Life Sci., 2012, 69(17), 2895-2906.
56. Wan, G.; Mathur, R.; Hu, X.; Zhang, X.; Lu, X., miRNA response to DNA damage. Trends Biochem. Sci., 2011, 36(9), 478-484.
57. Wouters, M. D.; van Gent, D. C.; Hoeijmakers, J. H.; Pothof, J. MicroRNAs, the DNA damage response and cancer. Mutation Res., 2011, 717(1-2), 54-66.
58. Wang, Y.; Taniguchi, T. MicroRNAs and DNA damage response: Implications for cancer therapy. Cell Cycle, 2013, 12(1), 32-42.
59. Butz, H.; Liko, I.; Czirjak, S.; Igaz, P.; Khan, M. M.; Zivkovic, V.; Balint, K.; Korbonits, M.; Racz, K.; Patocs, A., Down-regulation of Wee1 kinase by a specific subset of microRNA in human sporadic pituitary adenomas. J. Clin. Endocrinol. Metabolism, 2010, 95(10), E181-191.
60. Groesser, T.; Chang, H.; Fontenay, G.; Chen, J.; Costes, S. V.; Helen Barcellos-Hoff, M.; Parvin, B.; Rydberg, B. Persistence of gamma-H2AX and 53BP1 foci in proliferating and non-proliferating human mammary epithelial cells after exposure to gamma-rays or iron ions. Int. J. Radiat. Biol., 2011, 87(7), 696-710.
61. Wu, C. W.; Dong, Y. J.; Liang, Q. Y.; He, X. Q.; Ng, S. S.; Chan, F. K.; Sung, J. J.; Yu, J. MicroRNA-18a attenuates DNA damage repair through suppressing the expression of ataxia telangiectasia mutated in colorectal cancer. Plos One, 2013, 8(2), e57036.